NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 20 04:00PM ET
17.89
Dollar change
+0.11
Percentage change
0.62
%
IndexRUT P/E- EPS (ttm)- Insider Own23.36% Shs Outstand43.35M Perf Week-8.21%
Market Cap775.71M Forward P/E- EPS next Y-2.02 Insider Trans11.26% Shs Float33.23M Perf Month12.94%
Enterprise Value551.21M PEG- EPS next Q-0.46 Inst Own83.50% Short Float12.44% Perf Quarter14.02%
Income- P/S- EPS this Y74.29% Inst Trans37.02% Short Ratio7.47 Perf Half Y-
Sales- P/B2.47 EPS next Y8.49% ROA- Short Interest4.13M Perf YTD-24.29%
Book/sh7.24 P/C3.35 EPS next 5Y38.94% ROE- 52W High24.50 -26.98% Perf Year-
Cash/sh5.34 P/FCF- EPS past 3/5Y8.56% - ROIC- 52W Low8.89 101.24% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y1807.41% - Gross Margin- Volatility3.72% 4.89% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)1.39 Perf 10Y-
Dividend Ex-Date- Quick Ratio14.93 Sales Y/Y TTM- Profit Margin- RSI (14)55.04 Recom1.44
Dividend Gr. 3/5Y- - Current Ratio15.88 EPS Q/Q-50.30% SMA200.40% Beta- Target Price23.56
Payout- Debt/Eq0.02 Sales Q/Q111.25% SMA5023.78% Rel Volume0.66 Prev Close17.78
Employees291 LT Debt/Eq0.02 EarningsMay 06 AMC SMA20011.68% Avg Volume553.33K Price17.89
IPOJan 30, 2025 Option/ShortNo / Yes EPS/Sales Surpr.-95.50% 9.23% Trades Volume367,227 Change0.62%
Date Action Analyst Rating Change Price Target Change
Jun-16-25Initiated Truist Buy $26
Jun-12-25Initiated Lake Street Buy $30
May-30-25Initiated Wolfe Research Outperform $20
May-30-25Initiated Goldman Neutral $16
Feb-24-25Initiated Stifel Buy $25
Feb-24-25Initiated Piper Sandler Overweight $26
Feb-24-25Initiated Leerink Partners Outperform $28
Feb-24-25Initiated Lake Street Buy $30
Feb-24-25Initiated BofA Securities Buy
Feb-20-25Initiated Robert W. Baird Neutral $20
Jun-20-25 07:06AM
Jun-19-25 07:00AM
Jun-16-25 10:21AM
Jun-02-25 05:01AM
May-29-25 05:44AM
03:22AM Loading…
May-07-25 03:22AM
May-06-25 04:02PM
May-01-25 08:00AM
Apr-24-25 11:44AM
Apr-19-25 05:30AM
Apr-16-25 04:05PM
Apr-09-25 07:30AM
Mar-28-25 06:00AM
Mar-27-25 04:45PM
Mar-25-25 04:02PM
12:59PM Loading…
Mar-03-25 12:59PM
Feb-27-25 07:00AM
Feb-21-25 09:35AM
Jan-31-25 05:56PM
06:34AM
Jan-30-25 12:55PM
Jan-29-25 10:34PM
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sean SaintOfficerJun 02 '25Proposed Sale17.893,43961,524Jun 09 08:30 PM
Hopman MarkChief Commercial OfficerJun 02 '25Sale17.8986815,52934,132Jun 04 07:30 PM
Russell Steven JonChief Medical OfficerJun 02 '25Sale17.891,03918,58872,032Jun 04 07:30 PM
Mensinger MikeChief Product OfficerJun 02 '25Sale17.891,11519,94892,904Jun 04 07:30 PM
Feider StephenChief Financial OfficerJun 02 '25Sale17.891,49726,78345,503Jun 04 07:30 PM
Saint SeanPresident & CEOJun 02 '25Sale17.893,43961,526104,561Jun 04 07:30 PM
Mensinger MikeChief Product OfficerJan 31 '25Buy17.0033,350566,95059,019Feb 03 08:30 PM
Mensinger MikeChief Product OfficerJan 31 '25Sale17.001322125,669Feb 03 08:30 PM
Wellington Hadley Harbor Aggre10% OwnerJan 31 '25Buy17.001,000,00017,000,0003,901,599Feb 03 04:49 PM